Cargando…

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis

OBJECTIVES: Anti‐TIF1-gamma autoantibodies can be detected with immunoprecipitation (IP), line blot (LB) and ELISA. We compared assay performance in patients with DM and the potential of these assays to detect anti-TIF1-gamma positive cancer-associated DM (CADM). METHODS: We included sera from 131 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selickaja, Sandra, Galindo-Feria, Angeles S, Dani, Lara, Mimori, Tsuneyo, Rönnelid, Johan, Holmqvist, Marie, Lundberg, Ingrid E, Venalis, Paulius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707101/ https://www.ncbi.nlm.nih.gov/pubmed/35579337 http://dx.doi.org/10.1093/rheumatology/keac288

Ejemplares similares

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort
por: Galindo-Feria, Angeles S, et al.
Publicado: (2022)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
por: Ferronato, Marco, et al.
Publicado: (2023)

Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
por: TAKEZAKI, Daiki, et al.
Publicado: (2020)

The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population
por: Loganathan, Aravinthan, et al.
Publicado: (2022)

A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody Testing
por: Mulhearn, Ben, et al.
Publicado: (2022)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
por: Parkes, Joanna E., et al.
Publicado: (2018)

A New ELISA for Dermatomyositis Autoantibodies: Rapid Introduction of Autoantigen cDNA to Recombinant Assays for Autoantibody Measurement
por: Muro, Yoshinao, et al.
Publicado: (2013)

Immunoprecipitation and Western blot-based detection of protein O-GlcNAcylation in cells
por: Ahmed, Oumaima, et al.
Publicado: (2022)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders
por: Murakami, Kosaku, et al.
Publicado: (2018)

The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence
por: Worrall, Donovan, et al.
Publicado: (2023)

The identification of high-preforming antibodies for Ubiquilin-2 for use in Western Blot, immunoprecipitation, and immunofluorescence
por: McDowell, Ian, et al.
Publicado: (2023)

The identification of high-performing antibodies for Profilin-1 for use in Western blot, immunoprecipitation and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
por: Kryštůfková, Olga, et al.
Publicado: (2014)

Method for detecting acetylated PD-L1 in cell lysates by immunoprecipitation and western blot analysis
por: Middleton-Davis, Frances, et al.
Publicado: (2022)

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis
por: Kang, Eun Ha, et al.
Publicado: (2010)

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
por: Lerman, Irina, et al.
Publicado: (2019)

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report
por: Adhikari, Krishna, et al.
Publicado: (2023)

Comparisons of ELISA and Western blot assays for detection of autophagy flux
por: Oh, Sung-hee, et al.
Publicado: (2017)

The identification of high-performing antibodies for RNA-binding protein FUS for use in Western Blot, immunoprecipitation, and immunofluorescence
por: Alshalfie, Walaa, et al.
Publicado: (2023)

Near misdiagnosis of acute HIV-infection with ELISA-Western Blot scheme: Time for mindset change
por: Medina-De la Garza, Carlos Eduardo, et al.
Publicado: (2021)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

A Guide to Modern Quantitative Fluorescent Western Blotting with Troubleshooting Strategies
por: Eaton, Samantha L., et al.
Publicado: (2014)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

The identification of high-performing antibodies for Charged multivesicular body protein 2b for use in Western Blot, immunoprecipitation and immunofluorescence
por: Alshafie, Walaa, et al.
Publicado: (2023)

Comparison of Protein Immunoprecipitation-Multiple Reaction Monitoring with ELISA for Assay of Biomarker Candidates in Plasma
por: Lin, De, et al.
Publicado: (2013)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
por: Burbelo, Peter D., et al.
Publicado: (2010)

Identification of high-performing antibodies for Superoxide dismutase [Cu-Zn] 1 (SOD1) for use in Western blot, immunoprecipitation, and immunofluorescence
por: Ayoubi, Riham, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o9ngov17rcva3vs8d49ks1u9pq